Robin Chusid, 55, fought cancer for about a year. She seemed to have won, and danced at her son’s wedding one week after her last chemotherapy treatment in October.
But Chusid said she’s always afraid. Ovarian cancer recurs in 70 percent of women in remission, according to data from the nonprofit Ovarian Cancer Research Fund Alliance. The odds, she said, seem stacked against her.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
